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A wide variety of nanomaterials have demonstrated promise in medical applications such 
as drug delivery and imaging. In these applications, the surface chemistry of the materials 
is critical as it plays an important role in determining the toxicity and biodistribution 
behavior of the material. We review here the functionalization of nanomaterials with 
dendrons as an efficient method to alter the surface chemistry of the materials, introducing 
new properties and functions. Described here is the functionalization of superparamagnetic 
iron oxide nanoparticles (SPIO) with dendritic guanidines to enhance their transport into 
cells for magnetic resonance imaging applications. The introduction of dendrons bearing 
peripheral hydroxyls, amines, guanidines, carbohydrates and Gd(III) chelates to polymer 
vesicles (polymersomes) is also described. These dendritic moieties allow for modulation 
of toxicity, cell uptake, protein binding, and contrast agent efficiency, while at the same 
time allowing the stabilities of the polymersomes to be maintained. Thus, this approach 
holds promise for the development of a wide range of multifunctional materials for 
pharmaceutical applications.
Uniterms: Dendrimer. Superparamagnetic Iron Oxide Nanoparticles. Polymersome. 
Pharmaceutical applications.
Uma grande variedade de nanomateriais tem demonstrado aplicações médicas promissoras, 
tais como liberação de fármacos e em imagens. Nestas aplicações, a superfície química dos 
materiais é crítica, uma vez que exerce papel importante na determinação da toxicidade 
e comportamento de biodistribuição do material. Aqui, nós revisamos a funcionalização 
de nanomateriais, como dendrons, como método eficiente de alterar a superfície química 
destes compostos, introduzindo novas propriedades e funções. Descritos aqui estão 
nanopartículas superparamagnéticas de óxido de ferro (do inglês, SPIO), com guanidinas 
dendríticas para aumentar seu transporte para o interior das células, úteis em imagens de 
ressonância magnética. A introdução de dendrons contendo hidroxilas, aminas, guanidinas, 
carboidratos e quelatos de Gd(III) periféricos em vesículas poliméricas (polymersomes) 
também está descrita. Esses grupos dendríticos permitem a modulação de toxicidade, 
captura celular, ligação à proteína e eficiência como agente de contraste, enquanto que, ao 
mesmo tempo, permitem a manutenção da estabilidade das vesículas poliméricas. Assim, 
essa abordagem é promissora para o desenvolvimento de grande variedade de materiais 
multifuncionais para aplicações farmacêuticas.
Unitermos: Dendrímeros. Nanopartículas superparamagnéticas de óxido de ferro. Vesícula 
polimérica. Aplicações farmacêuticas.
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INTRODUCTION
In recent years, a diverse array of nanosized materi-
als has been investigated for biomedical applications. For 
example, polymer assemblies such as micelles and vesicles 
have been widely investigated as carriers that can encapsu-
late drugs and release them in a controlled manner, while 
at the same time prolonging their circulation time and 
protecting them from premature degradation (Choudhury, 
He, 2012; Ohya et al., 2012; Tian et al., 2012). Various 
nanogels, microparticles and nanoparticles composed 
of biodegradable polymers have also been investigated 
with similar goals (Balmert, Little, 2012; Balmert, Little, 
2012; Beck-Broichsitter et al., 2012; Patel et al., 2012). 
In medical imaging applications, superparamagnetic iron 
oxide nanoparticles (SPIO) have been demonstrated to 
provide contrast in a variety of applications owing to their 
ability to perturb local magnetic fields, leading to regions 
of hypointensity, or signal voids in images (Corot et al., 
2006; Laurent et al., 2008; Villaraza et al., 2010). Semi-
conductor nanocrystals, termed quantum dots, have been 
shown to provide enhanced optical properties relative to 
conventional fluorophores, leading to their use in vivo in 
optical imaging and cell tracking, high resolution cellular 
imaging, and the study of various cellular processes at the 
molecular level (Cinteza, 2010). Gold nanoparticles of 
various shapes and sizes are one of the most widely used 
classes of bionanomaterials with applications in imaging, 
diagnostics, photothermal therapy, drug and gene delivery 
and other areas (Dykman, Khlebtsov, 2012).
While the bulk composition of a bionanomaterial is 
important for its function and long-term biocompatibility, 
the functionalities present at its surface are also critical. It 
is the surface of a material that will first comes into contact 
with the biological system and as such will play a major 
role in its toxicity and biodistribution behavior (Yang et 
al., 2010). The surface can also provide sites for the in-
troduction of drugs and moieties to target the material to 
specific sites in vivo (Pang et al., 2010; Pittet et al., 2006). 
Furthermore, the high levels of multivalency available 
at the surface of a nanomaterial can provide therapeutic 
properties by inhibiting undesirable multivalent interac-
tions between host cells and pathogens including bacteria 
and viruses using ligands such as carbohydrates (Mammen 
et al., 1998; Rai et al., 2006).
Dendrimers are a class of macromolecules at the 
interface of polymer and synthetic organic chemistry. In 
contrast to hyperbranched polymers, which are prepared 
from branched (multifunctional) monomer units in a single 
polymerization reaction, resulting in incomplete branching 
and polydisperse materials, dendrimers are synthesized 
from branched monomer units in a stepwise manner, lead-
ing to monodisperse or very low polydispersity products 
(Tomalia et al., 1985; Frechet, Tomalia, 2001; Newkome 
et al., 2001). In addition, it is possible to achieve precise 
control over their molecular shape, dimensions, density, 
polarity, flexibility and solubility by choosing different 
building/branching units and surface functional groups 
(Tomalia et al., 1990; Caminade et al., 2005). Because of 
their monodispersities, high loading capacities, large-scale 
production, and bioconjugation capabilities, dendritic 
structures have been recognized to be ideal building blocks 
for biomedical applications (Gillies, Fréchet, 2005; Medi-
na, El-Sayed, 2009; Rolland et al., 2009; Jain et al., 2010).
Generally, dendrimers are globe- or ellipsoid-
shaped, and they consist of three distinct regions: a 
central core, repeated branches, and surface functional 
groups (Aulenta et al., 2003). The central core should be 
a molecule with at least two reactive functional groups. 
The repeated branches are organized in a series of radi-
ally concentric layers called “generations’’ (Caminade 
et al., 2005). When iterative growth is conducted from 
focal point or core molecule containing one reactive 
group, wedge-shaped structures, commonly referred to as 
“dendrons” result (Figure 1). In addition to the interest in 
dendrimers and dendrons for biomedical applications, our 
group has also been interested in the use of dendrons for 
the surface modification of bionanomaterials. It was antici-
pated that their high multivalency would be advantageous 
in terms of displaying ligands or other functionalities at the 
surfaces of materials, while at the same time their bulky 
FIGURE 1 - Schematic representation of a dendron showing 
the focal point, generations (G1, G2, and G3 represent the 
first, second and third generations respectively), and peripheral 
groups.
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architecture would make these moieties readily available 
at the surface rather than buried within the polymer layer 
at the surface. Here we will provide an overview of our 
group’s work in the introduction of dendritic groups to 
the surfaces of SPIO and polymersomes, and how this 
dendritic functionalization can be used to impart new 
properties and functions to these materials.
DENDRITIC FUNCTIONALIZATION OF SPIO
Magnetic resonance imaging (MRI) is an important 
non-invasive imaging technique for the study of biological 
processes, diagnosis of disease and the study of disease 
progression. MRI can be performed without contrast 
agents, but in many cases, the use of contrast agents can 
provide increased signal contrast between normal and 
diseased tissues, or aid in the understanding of biological 
phenomena. In addition to low molecular weight com-
plexes based on Gd(III), (Caravan et al., 1999; Merbach, 
Toth, 2001; Terreno et al., 2010) which are commonly 
used clinically, the development of new agents based on 
SPIO has been of significant interest over the last couple 
of decades (Corot et al., 2006; Laurent et al., 2008; Vil-
laraza et al., 2010). These nanoparticles induce local inho-
mogeneities in the magnetic field, resulting in regions of 
hypointensity in T2-weighted MR images. There are two 
primary means of administering SPIO. In one approach, 
SPIO is injected intravenously and arrives at the target site 
passively or through the conjugation of active targeting 
groups to the nanoparticle surface (Tsourkas et al., 2005; 
Lee et al., 2007). In another approach, in particular for the 
study of biological processes such as cancer metastasis 
and stem cell transplantation, cells are labeled with SPIO, 
implanted in vivo and then tracked by MRI (Bulte et al., 
2001; Pittet et al., 2006; Foster et al., 2008).
It has been found that even single SPIO labeled cells 
can be detected in vivo by MRI, demonstrating the im-
mense promise of cell tracking by MRI (Heyn et al., 2006). 
However, the ability to detect these labeled cells by MRI 
depends on the quantity of SPIO in the cells. While phago-
cytic cells such as macrophages can be readily labeled with 
SPIO, this labeling is more difficult for non-phagocytic 
cells such as cancer cells. For biomedical applications, 
SPIO is often coated with water-soluble polymers such 
as dextran (Weissleder et al., 1995) or poly (ethylene ox-
ide) (PEO), (Li et al., 2005) which impart solubility and 
biocompatibility, but do not enhance the cellular uptake 
of SPIO. Various transfection agents have been used to 
enhance the uptake of SPIO, but the complexes formed 
with these agents are often polydisperse and challenging to 
control (Frank et al., 2003). Alternatively, cell-penetrating 
peptides such as HIV-Tat (Josephson et al., 1999; Lewin 
et al., 2000) or protamine (Pittet et al., 2006) have been 
used, but there may be limitations with respect to the large 
scale preparation of these peptides and concerns regarding 
immunogenicity. To address these issues, we prepared a 
dendritic cell penetrating agent and conjugated it to SPIO 
to provide enhanced cell uptake (Martin et al., 2008).
It had been previously demonstrated by the groups 
of Goodman, (Chung et al., 2004) Wender (Wender et al., 
2005), and Harth (Huang et al., 2007) that it was possible 
to prepare dendrons functionalized at their peripheries 
with guanidines and that these could enhance the uptake 
of chromophores into cells in a manner similar to HIV-Tat 
and protamine, which contain high levels of the amino acid 
arginine. Thus, the concept of dendritic cell-penetrating 
agents seemed promising, but these agents had not previ-
ously been demonstrated to deliver large payloads such 
as nanoparticles into cells. A polyester dendron based on 
2,2-bis(hydroxymethyl)propionic acid was selected as 
the dendritic scaffold due to its ease of synthesis, biode-
gradability and biocompatibility (Gillies et al., 2005). A 
dendron having a focal point alkyne and eight peripheral 
guanidines was prepared by divergent growth of the 3rd 
generation dendron 1 from propargyl alcohol (Wu et al., 
2005), installation of peripheral amines using a protected 
b-alanine anhydride, deprotection to the amine terminated 
dendron 2 (Li et al., 2007), coupling of a protected guani-
dine derivative, and finally deprotection to provide den-
dron 3 (Figure 2) (Martin et al., 2008). Using a fluorescein 
derivative of 3, it was demonstrated by flow cytometry 
studies with GL261 mouse glioma cells that the efficacy 
of the fluorescein labelled dendritic guanidine transporter 
was comparable to that of a fluorescein labelled HIV-
Tat47-57 oligopeptide (FITC-LC-YGRKKRRQRRR-NH2) 
(Martin et al., 2008).
SPIO coated with dextran and functionalized with 
azides, as well as a rhodamine dye was prepared with the 
aim of performing the conjugation reaction between the 
dendrons and the SPIO by highly chemoselective and 
functional group tolerant Cu(I) catalyzed “click” cycload-
dition reactions (Lutz, Zarafshani, 2008). These cycload-
dition reactions have been found to be very high yielding, 
even in water and in the presence of significant steric 
hindrance, and were therefore ideal for the conjugation of 
macromolecules such as dendrons to nanoparticles (Helms 
et al., 2004). Dendrons 1 – 3 were conjugated to SPIO to 
provide SPIO with different dendritic surface coatings 
including hydroxyls, amines, and guanidines respectively 
(Figure 3) (Martin et al., 2008). Infrared (IR) spectroscopy 
was used to characterize the functionalized nanoparticles 
and it was found in the case of all three dendrons that the 
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click reaction proceeded to completion with complete dis-
appearance of the peak at 2100 cm-1 corresponding to the 
azide group. Dynamic light scattering (DLS) showed that 
the dendron-functionalized nanoparticles remained similar 
in size to the initial SPIO, with only a small increase in 
size and very minimal aggregation. In addition, transmis-
sion electron microscopy (TEM) was used to verify that 
the nanoparticle core was not affected. It was necessary to 
remove excess copper salts from the reaction mixture by 
dialysis against ethylenediaminetetraacetic acid (EDTA), 
followed by pure water.
The cell uptake of the SPIO into GL261 cells was 
investigated by flow cytometry based on the fluorescence 
of the rhodamine dye that was conjugated at the same 
density of each set of nanoparticles (Martin et al., 2008). 
After time points of 30 min and 2 h (Figure 4a), only the 
cells incubated with the dendritic guanidine functionalized 
particles exhibited significantly increased fluorescence. 
These results were confirmed by confocal microscopy, 
which demonstrated that the SPIO was indeed taken up 
by cells and not simply adsorbed on the cell surface. It 
was also demonstrated that this enhanced uptake led to 
an enhanced MRI response (Figure 4b). GL261 cells 
were labeled with the dendritic guanidine functionalized 
SPIO, and then washed and pelleted. T2 measurements of 
unlabeled and labeled cell pellets demonstrated a 10-fold 
reduction in T2 value for the labeled cells. This signifi-
cant difference in T2 values illustrates the utility of these 
nanoparticles for labeling cells for detection by MRI. The 
toxicities of the various nanoparticles were also investi-
gated in GL261 cells using an MTT assay (Figure 4c). 
(Freshney, 2000) Consistent with previous experiments 
demonstrating the high biocompatibilities of dendrimers 
based on 2,2-bis(hydroxymethyl)propionic acid (Gillies et 
al., 2005), the dendritic hydroxyl and the dendritic amine 
functionalized SPIO had a very similar toxicity to the 
dextran coated particles that are widely used for cell label-
ing applications. The dendritic guanidine functionalized 
particles exhibited somewhat increased toxicity at higher 
concentrations, but they remained relatively non-toxic at 
the low concentrations used for cell labeling. It is possible 
that their toxicity at higher concentrations arises from their 
ability to penetrate and create defects in cell membranes, 
as has been observed for various polycationic nanopar-
ticles and transporters (Leroueil et al., 2008).
Overall, this study demonstrated several key find-
ings. First, it represented the first successful example of the 
transport of a biologically relevant nanoparticle cargo by a 
dendritic guanidine transporter. The resulting system can 
provide improved labeling of cells with SPIO for enhanced 
sensitivity in cellular MRI. In addition, it demonstrated 
FIGURE 2 - Synthesis of hydroxyl 1, amine 2, and guanidine 3 
functionalized dendrons.
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that dendrons are an effective means of presenting biologi-
cally relevant functionality on a nanoparticle surface and 
a synthetic means for expanding this dendritic functional-
ization approach to a diverse array of azide functionalized 
nanomaterials.
DENDRITIC FUNCTIONALIZATION OF 
POLYMERSOMES
Over the past few decades, amphiphilic copolymers 
have been demonstrated to assemble into a vast array of 
morphologies ranging from spherical micelles (Alexan-
dridis, Lindman, 2000) to cylindrical micelles (Cai et 
al., 2007), helical rods (Cornelissen et al., 1998), toroids 
(Pochan et al., 2004), vesicles (Discher, Eisenberg, 2002; 
Zhang, Eisenberg, 1995), tubes (Yan et al., 2004), and 
multicompartment cylinders (Cui et al., 2007). Among 
these, polymer vesicles in particular, commonly referred 
to as polymersomes have received increasing attention. 
Interest in polymersomes can likely be attributed in part 
to their structural similarity to phospholipid vesicles (li-
posomes), which are important components of biological 
systems where they serve as cell membranes, and they 
have also been widely investigated in areas such as drug 
and gene delivery (Torchilin, Weissig, 2003). Like phos-
pholipid vesicles, polymersomes possess a hydrophobic 
membrane as well as an aqueous core, allowing for the 
incorporation of both hydrophilic and hydrophobic mol-
FIGURE 3 - “Click” conjugation of dendrons 1, 2, and 3 to azide functionalized SPIO to provide dendritic hydroxyl, amine, and 
guanidine functionalized SPIO respectively (Martin et al., 2008).
FIGURE 4 - a) Flow cytometry analyses of GL261 cells following incubation with dendron functionalized SPIO at a concentration 
of 25 µg Fe/mL for 2 h; b) MRI signal intensity of unlabelled cells and cells labelled with dendritic guanidine functionalized SPIO, 
measured at 3T using a spin echo sequence with varying echo times (TE); c) Viability of GL261 cells after 24 h incubation with 
dendron functionalized SPIO, as measured by the MTT assay. Error bars represent standard deviations on 3 measurements (Martin 
et al., 2008).
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FIGURE 5 - Schematic showing the functionalization of polymersomes bearing peripheral azide groups with dendrons having 
focal point alkynes.
ecules, and thus potentially multifunctional properties. 
In comparison with liposomes, polymersomes have been 
shown to exhibit properties such as increased strength 
and decreased permeability, which may be advantageous 
in their application as synthetic biomaterials (Discher et 
al., 1999; Discher, Eisenberg, 2002). Indeed, over the past 
decade there have been many reports emerging on their 
use as carriers of proteins (Ranquin et al., 2005; Liu et al., 
2010), hydrophilic drugs (Ahmed et al., 2006; Yang et al., 
2010), and imaging agents (Ghoroghchian et al., 2005).
As described above, the surface chemistry of 
polymersomes is critical in terms of controlling their 
interactions with biological systems. The introduction of 
dendritic groups via “click” [3+2] cyloaddition reactions 
of azide functionalized polymersomes with dendrons hav-
ing focal point alkynes provides the opportunity to alter 
the surface chemistry in a single step without changing 
the block copolymers comprising the polymersome mem-
branes. This provides a unique opportunity to impart new 
biological properties and functions.
In our initial work, as shown in Figure 5, poly-
mersomes composed of the amphiphilic linear diblock 
copolymer poly(butadiene-b-ethylene oxide) (PBD-PEO) 
were used (Li et al., 2007). An azide was introduced to the 
polymer terminus and polymersomes were prepared con-
taining varying ratios of the azide and hydroxyl terminated 
polymers. Dendron 2 having an alkyne focal point and 
peripheral amine groups was used and ~1 rhodamine dye 
per dendron was introduced to the dendron’s periphery in 
order to track and quantify the conjugation reaction. This 
dendron was reacted with the polymersomes under stan-
dard click conditions involving CuSO4, sodium ascorbate, 
and the ligand bathophenanthrolinedisulfonic acid. It was 
found that the use of this ligand prevented the adsorption 
of copper ions to the dendritic amines. The conjugation 
yields for the various polymersomes were quantified based 
on the UV-visible absorbance of the rhodamine dye on 
the dendrons.
As shown in Figure 6a, it was found that the conjuga-
tion yields were typically greater than 60% at low surface 
azide content (£ 20%) (Li et al., 2007). This was greater 
than expected as ~50% of the azides would be on the in-
terior of the polymersome and it was not expected that the 
dendrons could pass through the membrane into the poly-
mersome’s aqueous core. However, it is likely that through 
various processes, some interior azides can move to the 
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surface during the 24 h reaction. At higher azide content, 
the conjugation yields dropped off dramatically. This was 
attributed to steric hindrance at the polymersome surface 
due to the bulky nature of the dendrons. As these poly-
mersomes were micron-sized, they were also observed by 
fluorescence confocal microscopy. That the polymersomes 
were fluorescent was further confirmation of the successful 
conjugation of the rhodamine-labeled dendrons (Figure 
6b). In addition, well-dispersed polymersomes were ob-
served at low azide content. On the other hand, at higher 
azide content, significant aggregation was observed which 
may be attributed to either a disruption of the hydrophilic/
hydrophobic balance within the polymersome membrane 
upon dendron conjugation, or to interactions between the 
dendrons on different polymersomes. However, at azide 
content £ 20% this method was highly promising for the 
surface functionalization of polymersomes.
In a subsequent study, the surface functionaliza-
tion of PBD-PEO polymersomes with dendritic versus 
non-dendritic ligands was studied (Martin et al., 2009). 
Mannose was selected as the ligand as its multivalent 
binding to targets such as Concanavalin A (Con A) has 
been extensively investigated and a number of assays have 
been developed to evaluate this binding (Bittiger, 1976; 
Roy, 1996; Kanai et al., 1997; Gestwicki et al., 2002). 
Mannose functionalized dendron 4 (Figure 7), and a small 
molecule mannose derivative with an azide functionality 
were prepared (Martin et al., 2009). A dye-labeled ver-
sion of dendron 4 was used to quantify the conjugation 
to polymersomes and similar results to those described 
above for dendron 2 were obtained. As shown in Figure 
7a dendritic mannose polymersomes were prepared by the 
“click” conjugation of dendron 4 to polymersomes con-
taining 5% azide functionalized PBD-PEO. Non-dendritic 
mannose polymersomes were prepared by first conjugating 
the azide functionalized mannose to an alkyne-terminated 
PBD-PEO, and then assembly of polymersomes from 
a 50:50 mixture of mannose and hydroxyl-terminated 
polymers (Figure 7b). These quantities were selected in 
order to provide the same overall mannose content in the 
dendritic and non-dendritic polymersomes, but displayed 
in a different manner.
The dendritic and non-dendritic polymersomes 
were compared using a hemagglutination assay. In the 
presence of the protein Con A, red blood cells cluster 
due to interactions of cell surface carbohydrates with the 
protein. When mannose is present at a sufficiently high 
concentration, Con A binds preferentially to mannose and 
the clustering of the blood cells is inhibited. Comparisons 
of the minimum mannose concentration required to inhibit 
the agglutination can provide relative binding affinities 
of mannose-based ligands, which was the main point of 
interest in this study. The known small molecule ligand 
a-D-methyl mannopyranoside was used as a point of 
reference in this study. Despite their multivalency, the 
non-dendritic polymersomes provided only a very mod-
est 3.7-fold enhancement in affinity on a per mannose 
basis. In contrast, the dendritic mannose functionalized 
polymersomes provided a much greater 42-fold increase 
in relative binding affinity.
This enhancement relative to the non-dendritic 
system was attributed to several factors including the 
relatively rigid display of ligands on the dendritic scaf-
fold resulting in an entropic advantage (Mammen et al., 
1998), the ability of the dendritic scaffold to overcome 
steric inhibition of binding by the PEO layer (Lin et al., 
FIGURE 6 - a) Yield for the “click” conjugation between the dendron and polymersomes as a function of polymersome PBD-PEO-N3 
content (remainder is PBD-PEO-OH); b) Well dispersed polymersomes resulting from the conjugation of dendron to polymersomes 
composed of 5:95 PBD-PEO-N3:PBD-PEO-OH.
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2004), and an enhanced “proximity” effect resulting from 
the clustered display of ligands on the dendron (Lundquist, 
Toone, 2002). Through the preparation of the analogous 
dendritic and non-dendritic systems on dextran coated 
SPIO, it was demonstrated that these enhancements were 
generalizable to other nanoparticles and other polymer 
coatings in addition to PEO (Martin et al., 2009). Thus, 
this study revealed that it is important to consider carefully 
not only the choice of biological ligand, but also the mode 
in which it is conjugated to the surface in order to exploit 
the benefits of nanomaterials. Furthermore, it showed that 
dendritic scaffolds are an effective means of displaying 
biological ligands on surfaces.
As described above, the dendritic surface function-
alization approach provides a means of easily altering 
the polymersome surface chemistry in a single step. This 
provided the opportunity to explore the effect of the den-
dritic functionalization with different surface moieties on 
the physical and biological properties of polymersomes 
(Amos et al., 2012). In this case, in contrast to the microm-
eter-sized polymersomes described above, the PBD-PEO 
polymersomes were extruded through a 100 nm membrane 
to produce polymersomes with diameters of 100-200 nm 
that would be more suitable for biological applications. 
The azide and alkyne [3+2] cycloaddition was used to 
conjugate dendrons 1, 2, and 3 to polymersomes composed 
of 20% azide termined PBD-PEO (Figure 8). Because of 
the aggregation that had been previously observed upon 
conjugation of dendrons to vesicles with higher azide 
content (Li et al., 2007), we were interested in more subtle 
effects of the dendritic surface functionalization on the 
polymersome stability at lower azide content. This was 
probed first by measuring the release rate of an encapsu-
lated rhodamine dye from polymersomes functionalized 
with the different dendrons. As this dye molecule was 
known to traverse the polymersome membrane due to its 
balance of hydrophilicity and hydrophobicity this probed 
the effects of the dendrons on the membrane permeabil-
FIGURE 7 - Schematic for the preparation of a) dendritic mannose polymersomes; b) non-dendritic mannose polymersomes.
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FIGURE 8 - “Click” conjugation of dendrons 1, 2, and 3 to azide functionalized PBD-PEO polymersomes to provide dendritic 
hydroxyl, amine, and guanidine functionalized polymersomes respectively (Amos et al., 2012).
FIGURE 9 - a) Toxicity of naked and dendron functionalized PBD-PEO polymersomes as measured by an MTT assay following 48 
hour of incubation with HeLa cells; b) Quantitative comparison of the uptake of naked and dendritic hydroxyl, amine, and guanidine 
functionalized polymersomes in HeLa cells following a 1 h incubation at 37 °C, as measured by fluorescence confocal microscopy.
ity. No significant differences in the release rates of the 
dye from naked or the different dendritic functionalized 
polymersomes were observed, and in each case complete 
release was observed over a period of 10-15 h. The release 
of a rhodamine-labeled bovine serum albumin was also 
investigated. Because of its large size and high polarity/
charge, this protein was not expected to diffuse across 
the intact polymersome membrane and thus disruption 
of the membrane would be required for release. Again it 
was found that there were no significant differences in the 
release rates among the naked or different dendritic poly-
mersomes, and as expected the release was much slower 
for the protein, requiring 1-2 weeks to reach completion. 
Overall, these results demonstrated that the dendritic 
functionalization approach did not impart any inherent 
instability to the polymersomes.
The effects of the dendritic groups on the toxicities 
and cell uptakes of the polymersomes were also investi-
gated (Amos et al., 2012). In an MTT assay, as shown in 
Figure 9a, it was found that up to 1 mg/mL of polymer, 
the highest concentration evaluated, no significant toxic 
effects were observed for any of the samples except the 
dendritic guanidine functionalized polymersomes. This 
was not surprising in light of the previous results with the 
dendritic guanidine functionalized SPIO and can likely be 
attributed to the same causes (Martin et al., 2008). How-
ever, it was possible to administer these polymersomes 
without significant toxicity at lower concentrations. The 
cell uptake of the polymersomes was of particular interest 
due to the possibility of using polymersomes to encapsu-
late and deliver molecules such as DNA/RNA (Lomas et 
al., 2007; Christian et al., 2009; Cheng et al., 2011) and 
proteins, (Demirgoz et al., 2009; Cheng et al., 2011) which 
cannot normally diffuse through cell membranes. In this 
case, the uptake was studied using rhodamine-labeled 
polymersomes and the uptake was quantified by confocal 
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microscopy (Amos et al., 2012). It was found that the den-
dritic guanidine functionalized polymersomes exhibited a 
statistically significant increase in uptake relative to all of 
the other polymersome samples, showing that the dendritic 
guanidine is a versatile tool for the delivery of nanomateri-
als into cells (Figure 9b). The mechanism of cell uptake 
was investigated through temperature-dependent studies 
and by examining the colocalization of vesicles with Lyso-
Tracker ™ Blue. These studies suggested that endocytosis 
pathways likely play a major role in the internalization of 
these systems, though direct translocation may also play 
a small role.
While the above work demonstrated several impor-
tant properties and functions that can be imparted through 
dendritic surface functionalization of polymersomes, a 
limitation was the use of PBD-PEO. This copolymer is not 
biodegradable and while PEO is well established for bio-
medical applications, the PBD block presented concerns 
with respect to the long term behavior in vivo. To address 
this limitation, a system based on polycaprolactone (PCL)-
PEO block copolymers was developed. PCL is a well 
known biodegradable polymer that is currently approved 
for uses in tissue engineering (Jenkins et al., 2006; Lam 
et al., 2007) and drug delivery (Chandra, Rustgi, 1998; 
Sinha et al., 2004). A synthetic method was developed 
for the preparation of azide terminated (5) and hydroxyl 
terminated (6) PCL-PEO and these block copolymers 
were assembled into polymersomes by a nanoprecipita-
tion method involving the dissolution of the copolymer in 
tetrahydrofuran (THF), followed by a gradual addition of 
water, and finally dialysis against water to remove the THF 
(Figure 10a) (Nazemi et al., 2011). This led reproducibly 
to polymersomes with diameters of ~140 nm. It was pos-
sible to extrude these polymersomes to reduce their sizes 
to ~65 nm in diameter, an ideal size for in vivo circulation. 
By reducing the PCL content in the block copolymers, it 
was also possible to prepare micelles with diameters of ~ 
25 nm using a similar protocol (Figure 10b) (Nazemi et 
al., 2011).
The click functionalizations of the polymersomes 
and micelles with dendrons 2 and 3 were studied as de-
scribed above for the PBD-PEO polymersomes (Nazemi 
et al., 2011). With rhodamine-labelled version of dendron 
2, which had previous been studied quantitatively with 
PBD-PEO polymersomes, similar conjugation yields to 
the PCL-PEO polymersomes were obtained, as measured 
by UV-visible spectroscopy (Figure 11a). The yields 
were somewhat lower for rhodamine-labelled version of 
dendron 3, which was expected based on its larger size. 
For the micelles, it was expected that at low azide load-
ing the conjugation yield should approach 100% as all of 
the azides should be on the micelle surface. However, as 
shown in Figure 11b, this was not the case and the yields 
were similar to those obtained for the polymersomes. The 
FIGURE 10 - Assembly of PCL-PEO diblock copolymers into a) vesicles; b) micelles.
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FIGURE 11 - Yields for the “click” conjugation between the rhodamine-labelled versions of dendrons 2 or 3 and PCL-PEO a) 
vesicles, and b) micelles as a function of PCL-PEO-N3 content (remainder is PCL-PEO-OMe).
reasons for these lower yields are still unclear at this time, 
but can perhaps be related to the large size of the dendrons 
relative to the micelles.
TEM was used to confirm that both the micelles 
and polymersomes remained intact following the 
dendron conjugation. However, upon removal of the 
excess dendron by dialysis, significant aggregation was 
observed for the polymersomes, even at relatively low 
azide content, unlike for the PBD-PEO polymersomes. 
Thus, the PEO-PCL polymersomes appear to be more 
sensitive to aggregation. The reasons for the differences 
between the two different polymersomes is not clear, 
but aggregation is believed to result from the cationic 
charges on dendrons 2 and 3 as studies with hydroxyl 
terminated dendrons, even of higher generation did not 
result in aggregation. The removal of the excess dendron 
by dialysis at a variety of pHs and ionic strengths was 
investigated with the aim of preventing aggregation was 
investigated, but unfortunately the aggregation could not 
be prevented. The micelle systems proved much less sus-
ceptible to aggregation, a result likely attributable to their 
different morphologies. Thus, this work demonstrated 
that the dendritic functionalization approach could be 
extended to biodegradable PCL-PEO polymersomes and 
also to micelles formed from these polymers. Aggrega-
tion was problematic for polymersomes functionalized 
with dendrons bearing cationic peripheral groups, but 
not for those with neutral hydroxyl groups, and not for 
the micelles, even with cationic dendrons.
The above work lay the groundwork for the use 
of PCL-PEO polymersomes in specific biomedical ap-
plications. In a first demonstration of their utility, PCL-
PEO polymersomes were used to prepare an enhanced 
Gd(III)-based MRI contrast agent (Nazemi et al., 2012). 
As described above in the context of SPIO, MRI is an 
important noninvasive imaging modality. Most clinically 
used contrast agents for MRI are based on small molecule 
chelates of Gd(III) (Caravan et al., 1999; Merbach, Toth, 
2001; Terreno et al., 2010). While the availability of these 
agents has enabled significant developments in MRI, they 
do suffer from some significant limitations including their 
low longitudinal relaxivities (r1), typically in the range 
of 3 - 5 mM-1s-1, and their short circulation half lives 
(Caravan, 2006). These limitations result in the require-
ment for large doses and also limits their applicability in 
molecular imaging (Prince et al., 2009). To address these 
limitations, Gd(III) complexes have been conjugated to a 
wide variety of macromolecular scaffolds including den-
drimers (Gang et al., 2010; Kobayashi, Brechbiel, 2005), 
linear polymers (Allen et al., 2006), proteins (Caravan et 
al., 2002), viral particles (Hooker et al., 2007), micelles 
(Accardo et al., 2004), liposomes (Schühle et al., 2010), 
and polymersomes (Cheng, Tsourkas, 2008; Grüll et al., 
2010). This can result in improvements in r1 values due 
to the slower tumbling rates of macromolecules and the 
resulting increases in the rotational correlation times of the 
Gd(III) (Caravan, 2006; Villaraza et al., 2010). In addi-
tion, macromolecular systems can exhibit prolonged blood 
circulation times (Gillies et al., 2005). Polymersomes are 
a particularly promising scaffold for the development 
of enhanced MRI contrast agents due to their inherently 
multifunctional character as different functions such as 
multimodal imaging agents and drug molecules can be 
incorporated onto their surface, inside the membrane, or 
inside the aqueous core.
In this study, it was hypothesized that while the 
conjugation of Gd(III) complexes to high generation 
dendrimers is known to enhance their relaxivities, im-
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The relaxivities of agents 11, 12, and 15 were mea-
sured at various magnetic field strengths using a field cy-
cling relaxometer (Nazemi et al., 2012). On a per Gd(III) 
basis, dendron 11 and polymersomes 12 and 15 exhibited 
r1 values of 12.1 ± 0.3, 26.1 ± 1.2, and 10.6 ± 0.4 mM-1s-1, 
respectively (20 MHz, 298 K). In comparison with the 
clinical agent Magnevist® (Gd(III)-DTPA) which has a 
relaxivity of 4.6 mM-1s-1 under the same conditions, this 
corresponds to 2.6-, 5.7-, and 2.3-fold increases in r1 for 
dendron 11, and polymersomes 12 and 15 respectively. 
The result for the dendron was in the expected range 
based on results for previous dendritic Gd(III) chelates 
of similar dendrimer generation (Kobayashi, Brechbiel, 
2005; Gang et al., 2010). The enhancement in relaxiv-
ity relative to the small molecule was attributed to the 
crowded nature of the dendron periphery, which inhibits 
free rotation of the Gd(III) complexes, thus increasing 
the rotational correlation time. The enhancement for the 
mobilization on the polymersome surface should provide 
further enhancements in relaxivity, while opening pos-
sibilities for the multifunctional opportunities described 
above (Nazemi et al., 2012). To evaluate this hypothesis, 
three different contrast agents were prepared and studied. 
As shown in Figure 12a, an isothiocyanate derivative 9 
of the clinically used diethylenetriaminepentaacetic acid 
(DTPA) chelate was reacted with dendron 2 to provide the 
dendritic chelate 10 in which Gd(III) was coordinated to 
provide the dendritic Gd(III) complex 11. Dendron 11 was 
coupled to PCL-PEO polymersomes having a diameter 
of 140 nm to provide the dendritic polymersome contrast 
agent 12. On the other hand, as shown in Figure 12b, 9 
was first reacted with propargyl amine to obtain the click-
able DTPA derivative 13. This molecule was then used to 
chelate Gd(III) to provide compound 14 which was then 
coupled to polymersomes to provide the non-dendritic 
polymersome contrast agent 15.
FIGURE 12 - Preparation of a) dendritic Gd(III) and dendritic Gd(III) functionalized polymersomes; b) non-dendritic Gd(III) and 
non-dendritic Gd(III) functionalized polymersomes.
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non-dendritic polymersomes was also likely due to the 
hindered motion of the complexes at the vesicle surface, 
as well as the slow tumbling rate of the entire vesicle 
system, though the PEO chains introduce some flexibil-
ity to the system. When both the dendritic and polymer 
components were combined in 12, the resulting r1 was the 
highest reported for a polymersome agent. The additive 
effect can result from the availability of the chelates at 
the vesicle surface for water exchange, the hindered mo-
tion of the Gd(III) chelate at the local level imparted by 
the dendritic structure, and the large size and thus slow 
tumbling rate of the polymersome at the nanoscale level. 
Thus, this study demonstrated that different nanoscale 
components can be readily combined to provide additive 
effects on relaxivity, while at the same time providing 
opportunities to exploit the multifunctional potential of 
polymersomes.
CONCLUDING REMARKS AND FUTURE DI-
RECTIONS
A method has been developed for the conjugation 
of dendrons to the surfaces of nanomaterials. Thus far, 
the nanomaterials investigated have been dextran coated 
SPIO, PBD-PEO polymersomes and PCL-PEO polymer-
somes and micelles, while the dendrons can have periph-
eral hydroxys, amines, guanidines, carbohydrates or metal 
chelates. The only requirement is the presence of azide 
moieties on the surface of the nanomaterial and an alkyne 
at the focal point of the dendron, so it is a highly versatile 
strategy. In general, it has been found that the yields of 
the azide + alkyne [3+2] cycloaddition reactions are high 
when the densities of azides on the nanomaterial surface 
FIGURE 13 - Longitudinal relaxivity (r1) of dendron 11, 
polymersome 12, and polymersome 15 in phosphate buffer (0.1 
M, pH 7.4) as a function of field strength at 298 K.
are relatively low, while at higher densities the yields 
become lower, which is believed to result from steric hin-
drance at the surface. Most dendron-functionalized materi-
als retained their original morphologies and remained well 
dispersed in solution. However PCL-PEO polymersomes 
exhibited a tendency to aggregate upon the conjugation 
of cationic dendrons.
An advantage of this dendritic functionalization 
strategy is that because of the multivalency of dendrons, 
it is an efficient means of significantly altering the surface 
chemistry of a material in a single step, without chang-
ing the core composition of the material. This has been 
used to study the effects of surface chemistry on the 
properties of materials. In vitro studies have shown that 
release kinetics of small and large molecules, toxicity, 
and cell uptake are unaffected by changing the surface 
groups of polymersomes with the exception of dendritic 
guanidines, which imparted cell penetrating properties. 
Though these dendritic guanidines do impart moderate 
levels of toxicity at higher concentrations, they have 
proved to be a versatile approach for enhancing the 
delivery of SPIO, vesicles, and micelles into cells. This 
can provide important functions such as enhancing the 
sensitivity of MRI and improving the delivery of encap-
sulated drug molecules into cells. Another important 
function that has been demonstrated is the enhancement 
in binding of dendritic ligands to protein targets, which 
has implications for both targeted delivery and multiva-
lent therapeutics. In addition, a significant enhancement 
in the relaxivity of an MRI contrast agent was achieved 
using a dendritic vesicle system.
Future work will include the continued application 
of the dendritic functionalization approach to the devel-
opment of new functional materials. For example, while 
the enhancement in protein binding of dendritic ligands 
was demonstrated with mannose, there are numerous 
other ligands such as carbohydrates and peptides that 
can provide enhanced therapeutic and targeting efficacy 
when presented in a multivalent manner. Furthermore, 
it will be important to exploit the multifunctionality of 
materials such as vesicles where in addition to the surface 
functionalization, therapeutics and/or imaging agents can 
be incorporated into the membrane or core.
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